Company: G
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001398659-25-000109
Chunk: 83

Company: Genpact LTD
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 83
---
 grant using the following valuation assumptions:Nine months ended September 30, 2024Nine months ended September 30, 2025Dividend yield1.62 %— 1.81 %1.37%Expected life (years)2.38— 2.802.81Risk-free rate for expected life 3.83 %— 4.37 %3.89%Volatility for expected life 24.24 %— 26.33 %25.78%A summary of PU activity during the nine months ended September 30, 2025 is set out below: Nine months ended September 30, 2025Number of Performance UnitsWeighted Average Grant Date Fair ValueMaximum Shares Eligible to ReceiveOutstanding as of January 1, 20253,257,804 $39.77 6,204,877Granted874,139 53.922,097,934Vested (Note a)(1,154,998)44.50(1,154,998)Forfeited(290,064)39.45(696,154)Outstanding as of September 30, 20252,686,881 42.386,451,659Expected to vest (Note b)2,755,910   (a)1,154,998 PUs vested during the nine months ended September 30, 2025, in respect of which 738,490 shares (net of minimum statutory tax withholding) were issued during the nine months ended September 30, 2025.(b)The number of PUs expected to vest is based on the probable achievement of the performance targets after considering an estimated forfeiture rate.

38

GENPACT LIMITED AND ITS SUBSIDIARIESNotes to the Consolidated Financial Statements(Unaudited)(In thousands, except per share data and share count)

15. Stock-based compensation (Continued)As of September 30, 2025, the total remaining unrecognized stock-based compensation cost related to PUs amounted to $62,212, which will be recognized over the weighted average remaining requisite vesting period of 1.9 years.Employee Stock Purchase Plan (ESPP)On May 1, 2008, the Company adopted the Genpact Limited U.S. Employee Stock Purchase Plan and the Genpact Limited International Employee Stock Purchase Plan (together, the “ESPP”). In April 2018, these plans were amended